Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • The Council of Scientific and Industrial Research (CSIR) has adopted a five-tier strategy to fight Covid-19, which is also getting wide support from the industry to implement it. This information was provided by Dr. Shekhar C. Mande, Director General of CSIR. He was addressing an online zoom meeting with directors of 38 laboratories of CSIR to discuss the strategy related to Covid-19.

  • A lawsuit is filed against Aurobindo Pharma and Emcure Pharma by MSP Recovery Claims in Florida, USA which claims that these pharmaceutical companies hide details about presence of carcinogenic element in anti-diabetic medicines reported by law360.

    On 2nd March 2020, Valisure has tested and detected high levels of N-Nitrosodimethylamine (NDMA) in specific lots of the drug metformin, a prescription medication used to control high blood sugar in adults and adolescents with type 2 diabetes.

    Valisure’s analysis of 22 companies selling metformin and a total of 38 batches revealed 16 batches and 11 companies where NDMA levels were detected above the 96 nanograms (ng) daily acceptable intake limit.

    The Defendants knowingly and with an intent to defraud, concealed from Plaintiff and Class Members the material facts concerning their pervasive cGMP violations, and made express and implied representations to Plaintiff’s assignors and Class Members that their Metformin drugs conformed to applicable standards of quality, purity, identity and strength, were not adulterated, and were merchantable, fit for human consumption and fit for their intended purpose when, in truth and in fact, the Metformin drugs were contaminated with a probable human carcinogen.

    MSP recovery claimed in petition that, "each package of Metformin drugs sold in the United States contained a printed insert, which represented that the drug in the package had the specified properties, conformed to the specified description, and carried a guarantee of quality assurance. The Defendants knowingly or extremely recklessly made these representations with actual knowledge, or reason to know, that they were false."


    Florida class action seeking to recover USd 124 million that health insurers paid for the popular diabetes drug.

    << Back to Pharma News

    Subscribe to PharmaTutor News Alerts by Email

  • Supply lines from abroad opened up today with the receipt of 1.70 lakh Personal Protection Equipment (PPE) coveralls from China which have been donated to the Government of India. Along with domestic supplies of 20,000 coveralls, a total of 1.90 lakh coveralls will now be distributed to hospitals and will add to the 3,87,473 PPEs already available in the country as of now. A total of 2.94 lakh PPE coveralls have been arranged and supplied by Government of India now.

  • A new study in Neuron offers clues to why autism spectrum disorder (ASD) is more common in boys than in girls. National Institutes of Health scientists found that a single amino acid change in the NLGN4 gene, which has been linked to autism symptoms, may drive this difference in some cases. The study was conducted at NIH’s National Institute of Neurological Disorders and Stroke (NINDS).

  • The U.S. Food and Drug Administration continues to play a critical role in accelerating medical countermeasures to treat and prevent COVID-19. As part of the response to this pandemic, the agency is taking the lead on a national effort to facilitate the development of, and access to, two investigational therapies derived from human blood. These are called convalescent plasma and hyperimmune globulin and are antibody-rich blood products made from blood donated by people who have recovered from the virus.

Subscribe to Pharma News